Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
CTI Biopharma
CTI Biopharma
(CTIC)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Vonjo
Pacritinib
2022-02-28
2028-2030
Primary myelofibrosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pacritinib
healthy volunteers/patients
,
drug interactions
,
myeloid leukemia acute
,
myeloid leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
myelomonocytic leukemia chronic
,
myelomonocytic leukemia acute
,
leukemia myeloid chronic atypical bcr-abl negative
,
myelomonocytic leukemia juvenile
,
syndrome
,
renal insufficiency
,
liver diseases
,
hepatic insufficiency
,
leukemia
,
myelodysplastic syndromes
,
preleukemia
,
neoplasms
,
myeloproliferative disorders
,
graft vs host disease
,
covid-19
,
colorectal neoplasms
,
primary myelofibrosis
,
polycythemia vera
,
essential thrombocythemia
,
thrombocytosis
,
polycythemia
,
thrombocytopenia
Tartrate
non-small-cell lung carcinoma
,
lung neoplasms
Albumin
non-small-cell lung carcinoma
,
lung neoplasms
Cilmostim
covid-19
Aglatimagene besadenovec
prostatic neoplasms
Glutamic acid
ovarian neoplasms
Pixantrone
neoplasms
,
b-cell chronic lymphocytic leukemia
,
second primary neoplasms
,
neoplasm metastasis
,
myeloid leukemia acute
,
myeloid leukemia
,
lymphoma
,
non-hodgkin lymphoma
,
follicular lymphoma
,
b-cell lymphoma
,
large b-cell lymphoma diffuse
,
leukemia
,
aggression
Sodium ascorbate
multiple myeloma
,
stem cell transplantation
,
plasma cell neoplasms
Sodium lactate
neoplasms
,
myeloproliferative disorders
,
non-hodgkin lymphoma
,
lymphoma
,
leukemia
Bevifimod
drug interactions
,
graft vs host disease
,
covid-19
Palifosfamide
non-hodgkin lymphoma
,
lymphoma
TOSEDOSTAT
healthy volunteers/patients
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
Microcrystalline cellulose
neoplasms
,
myeloproliferative disorders
,
non-hodgkin lymphoma
,
lymphoma
,
leukemia
Retinol
multiple myeloma
,
stem cell transplantation
,
plasma cell neoplasms
,
colorectal neoplasms
D-glutamate
ovarian neoplasms
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use